| Year |
Citation |
Score |
| 2020 |
Jenkinson S, Goody SMG, Bassyouni A, Jones R, Otto-Bruc A, Duquennoy S, DaSilva JK, Butler P, Mead A. Translation of in vitro cannabinoid 1 receptor agonist activity to in vivo pharmacodynamic endpoints. Journal of Pharmacological and Toxicological Methods. 106899. PMID 32702414 DOI: 10.1016/J.Vascn.2020.106899 |
0.347 |
|
| 2016 |
Wager TT, Chappie TA, Horton D, Chandrasekaran RY, Samas BM, Dunn-Sims E, Hsu C, Nawreen N, Vanase-Frawley MA, O'Connor RE, Schmidt C, Dlugolenski K, Stratman NC, Majchrzak MJ, Kormos BL, ... ... Mead AN, et al. Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects. Acs Chemical Neuroscience. PMID 27715007 DOI: 10.1021/Acschemneuro.6B00297 |
0.363 |
|
| 2014 |
Mead AN. Appropriate experimental approaches for predicting abuse potential and addictive qualities in preclinical drug discovery. Expert Opinion On Drug Discovery. 9: 1281-91. PMID 25176123 DOI: 10.1517/17460441.2014.956077 |
0.323 |
|
| 2013 |
Horton DB, Potter DM, Mead AN. A translational pharmacology approach to understanding the predictive value of abuse potential assessments. Behavioural Pharmacology. 24: 410-36. PMID 23873088 DOI: 10.1097/Fbp.0B013E3283644D2E |
0.314 |
|
| 2011 |
O'Connor EC, Chapman K, Butler P, Mead AN. The predictive validity of the rat self-administration model for abuse liability. Neuroscience and Biobehavioral Reviews. 35: 912-38. PMID 21036191 DOI: 10.1016/J.Neubiorev.2010.10.012 |
0.311 |
|
| 2011 |
Tyszkiewicz CM, Mead A. Drug-induced anxiety and the elevated plus maze: Effect of lighting conditions Journal of Pharmacological and Toxicological Methods. 64: e24. DOI: 10.1016/J.Vascn.2011.03.087 |
0.34 |
|
| 2010 |
O'Connor EC, Mead AN. Tramadol acts as a weak reinforcer in the rat self-administration model, consistent with its low abuse liability in humans. Pharmacology, Biochemistry, and Behavior. 96: 279-86. PMID 20580909 DOI: 10.1016/J.Pbb.2010.05.018 |
0.364 |
|
| 2010 |
O'Connor EC, Crombag HS, Mead AN, Stephens DN. The mGluR5 antagonist MTEP dissociates the acquisition of predictive and incentive motivational properties of reward-paired stimuli in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1807-17. PMID 20375996 DOI: 10.1038/Npp.2010.48 |
0.751 |
|
| 2010 |
O'Connor EC, Parker D, Rollema H, Mead AN. The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats. Psychopharmacology. 208: 365-76. PMID 19967529 DOI: 10.1007/S00213-009-1739-5 |
0.309 |
|
| 2010 |
O’Connor EC, Crombag H, Mead A, Engblom D, Stephens D. Incentive learning and the psychomotor activating effects of cocaine are controlled by mGluR5 in dopaminoceptive neurons F1000research. 1. DOI: 10.7490/F1000Research.734.1 |
0.647 |
|
| 2007 |
Mead AN, Zamanillo D, Becker N, Stephens DN. AMPA-receptor GluR1 subunits are involved in the control over behavior by cocaine-paired cues. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 343-53. PMID 16495937 DOI: 10.1038/Sj.Npp.1301045 |
0.689 |
|
| 2007 |
Boshoff EL, Staveley SM, Mead AN, Butler P. THE USE OF THE RAT DRUG DISCRIMINATION PARADIGM IN ASSESSMENT OF ABUSE LIABILITY Journal of Pharmacological and Toxicological Methods. 56: e48. DOI: 10.1016/J.Vascn.2007.02.097 |
0.314 |
|
| 2006 |
Mead AN, Morris HV, Dixon CI, Rulten SL, Mayne LV, Zamanillo D, Stephens DN. AMPA receptor GluR2, but not GluR1, subunit deletion impairs emotional response conditioning in mice. Behavioral Neuroscience. 120: 241-8. PMID 16719688 DOI: 10.1037/0735-7044.120.2.241 |
0.747 |
|
| 2005 |
Mead AN, Brown G, Le Merrer J, Stephens DN. Effects of deletion of gria1 or gria2 genes encoding glutamatergic AMPA-receptor subunits on place preference conditioning in mice. Psychopharmacology. 179: 164-71. PMID 15619119 DOI: 10.1007/S00213-004-2071-8 |
0.719 |
|
| 2005 |
Stephens D, Mead A. S6 EXPLORING THE ROLE OF AMPA RECEPTOR SUBUNITS IN ADDICTIVE PROCESSES USING MICE WITH TARGETED DELETIONS OF GLUR1 AND GLUR2 SUBUNITS Behavioural Pharmacology. 16: S2. DOI: 10.1097/00008877-200509001-00006 |
0.614 |
|
| 2004 |
Stephens DN, Mead AN. Behavioural plasticity-induced changes in drug response. Commentary on Badiani and Robinson drug-induced neurobehavioral plasticity: the role of environmental context. Behavioural Pharmacology. 15: 377-80. PMID 15343063 DOI: 10.1097/00008877-200409000-00011 |
0.6 |
|
| 2004 |
Mead AN, Crombag HS, Rocha BA. Sensitization of psychomotor stimulation and conditioned reward in mice: differential modulation by contextual learning. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 249-58. PMID 12942147 DOI: 10.1038/Sj.Npp.1300294 |
0.709 |
|
| 2003 |
Mead AN, Stephens DN. Involvement of AMPA receptor GluR2 subunits in stimulus-reward learning: evidence from glutamate receptor gria2 knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 9500-7. PMID 14573529 DOI: 10.1523/Jneurosci.23-29-09500.2003 |
0.72 |
|
| 2003 |
Stephens DN, Mead AN. What role do GluR1 subunits play in drug abuse? Trends in Neurosciences. 26: 181-2; author reply . PMID 12689767 DOI: 10.1016/S0166-2236(03)00080-8 |
0.609 |
|
| 2003 |
Mead AN, Stephens DN. Selective disruption of stimulus-reward learning in glutamate receptor gria1 knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 1041-8. PMID 12574434 DOI: 10.1523/Jneurosci.23-03-01041.2003 |
0.709 |
|
| 2002 |
Rocha BA, Goulding EH, O'Dell LE, Mead AN, Coufal NG, Parsons LH, Tecott LH. Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 10039-45. PMID 12427861 DOI: 10.1523/Jneurosci.22-22-10039.2002 |
0.442 |
|
| 2002 |
Stephens DN, Mead AN, Ripley TL. Studying the neurobiology of stimulant and alcohol abuse and dependence in genetically manipulated mice. Behavioural Pharmacology. 13: 327-45. PMID 12394407 DOI: 10.1097/00008877-200209000-00004 |
0.602 |
|
| 2002 |
Rocha BA, Mead AN, Kosofsky BE. Increased vulnerability to self-administer cocaine in mice prenatally exposed to cocaine. Psychopharmacology. 163: 221-9. PMID 12202969 DOI: 10.1007/S00213-002-1140-0 |
0.424 |
|
| 2002 |
Mead AN, Rocha BA, Donovan DM, Katz JL. Intravenous cocaine induced-activity and behavioural sensitization in norepinephrine-, but not dopamine-transporter knockout mice. The European Journal of Neuroscience. 16: 514-20. PMID 12193195 DOI: 10.1046/J.1460-9568.2002.02104.X |
0.429 |
|
| 2002 |
Highfield DA, Mead AN, Grimm JW, Rocha BA, Shaham Y. Reinstatement of cocaine seeking in 129X1/SvJ mice: effects of cocaine priming, cocaine cues and food deprivation. Psychopharmacology. 161: 417-24. PMID 12073170 DOI: 10.1007/S00213-002-1047-9 |
0.42 |
|
| 2002 |
Mead AN, Katz JL, Rocha BA. Intravenous cocaine-induced activity in A/J and C57BL/6J mice: behavioral sensitization and conditioned activity. Neuropharmacology. 42: 976-86. PMID 12069908 DOI: 10.1016/S0028-3908(02)00048-5 |
0.466 |
|
| 2001 |
Bronsert MR, Mead AN, Hen R, Rocha BA. Amphetamine-induced locomotor activation in 5-HT(1B) knockout mice: effects of injection route on acute and sensitized responses. Behavioural Pharmacology. 12: 549-55. PMID 11795245 |
0.302 |
|
| 2000 |
Jackson A, Mead AN, Stephens DN. Behavioural effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate-receptor antagonists and their relevance to substance abuse. Pharmacology & Therapeutics. 88: 59-76. PMID 11033384 DOI: 10.1016/S0163-7258(00)00078-4 |
0.659 |
|
| 2000 |
Dunworth SJ, Mead AN, Stephens DN. Previous experience of withdrawal from chronic diazepam ameliorates the aversiveness of precipitated withdrawal and reduces withdrawal-induced c-fos expression in nucleus accumbens. The European Journal of Neuroscience. 12: 1501-8. PMID 10762378 DOI: 10.1046/J.1460-9568.2000.00036.X |
0.643 |
|
| 1999 |
Mead AN, Vasilaki A, Spyraki C, Duka T, Stephens DN. AMPA-receptor involvement in c-fos expression in the medial prefrontal cortex and amygdala dissociates neural substrates of conditioned activity and conditioned reward. The European Journal of Neuroscience. 11: 4089-98. PMID 10583497 DOI: 10.1046/J.1460-9568.1999.00828.X |
0.657 |
|
| 1999 |
Mead AN, Stephens DN. CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors. The Journal of Pharmacology and Experimental Therapeutics. 290: 9-15. PMID 10381753 |
0.623 |
|
| 1998 |
Mead AN, Stephens DN. AMPA-receptors are involved in the expression of amphetamine-induced behavioural sensitisation, but not in the expression of amphetamine-induced conditioned activity in mice. Neuropharmacology. 37: 1131-8. PMID 9833643 DOI: 10.1016/S0028-3908(98)00101-4 |
0.699 |
|
| 1998 |
Jackson A, Mead AN, Rocha BA, Stephens DN. AMPA receptors and motivation for drug: effect of the selective antagonist NBQX on behavioural sensitization and on self-administration in mice. Behavioural Pharmacology. 9: 457-67. PMID 9832931 DOI: 10.1097/00008877-199809000-00009 |
0.691 |
|
| 1998 |
Mead AN, Stephens DN. THE ROLE OF AMPA RECEPTORS IN CONDITIONED REINFORCEMENT Behavioural Pharmacology. 9: S61. DOI: 10.1097/00008877-199808000-00133 |
0.622 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2014 |
Wager TT, Chandrasekaran RY, Bradley J, Rubitski D, Berke H, Mente S, Butler T, Doran A, Chang C, Fisher K, Knafels J, Liu S, Ohren J, Marconi M, DeMarco G, ... ... Mead A, et al. Casein kinase 1δ/ε inhibitor PF-5006739 attenuates opioid drug-seeking behavior. Acs Chemical Neuroscience. 5: 1253-65. PMID 25299732 DOI: 10.1021/Cn500201X |
0.297 |
|
| 2011 |
Tyszkiewicz CM, Cannon KE, Mead A. Optimizing learned helplessness testing conditions to detect changes in behavioral despair Journal of Pharmacological and Toxicological Methods. 64: e21-e22. DOI: 10.1016/J.Vascn.2011.03.078 |
0.292 |
|
| 2017 |
Nickolls SA, Gurrell R, van Amerongen G, Kammonen J, Cao L, Brown AR, Stead C, Mead A, Watson C, Hsu C, Owen RM, Pike A, Fish RL, Chen L, Qiu R, et al. Pharmacology in translation; the preclinical and early clinical profile of the novel α2/3 functionally selective GABAA receptor positive allosteric modulator PF-06372865. British Journal of Pharmacology. PMID 29214652 DOI: 10.1111/Bph.14119 |
0.289 |
|
| 2013 |
Rosado A, Mead A, DaSilva J. Establishing the EEG Sleep Profile of Cocaine Withdrawal in Sprague–Dawley rats Journal of Pharmacological and Toxicological Methods. 68: e8. DOI: 10.1016/J.Vascn.2013.01.039 |
0.289 |
|
| 2007 |
O'Connor EC, Mead AN, Staveley SM, Pertinez H, Butler P. THE RAT SELF-ADMINISTRATION MODEL AND DETERMINING THE ABUSE POTENTIAL OF NEW CHEMICAL ENTITIES — A FOCUS ON CNS STIMULANTS Journal of Pharmacological and Toxicological Methods. 56: e39. DOI: 10.1016/J.Vascn.2007.02.079 |
0.278 |
|
| 2013 |
Nawreen N, Tyszkiewicz C, Roberts D, Parker D, Mead A. Self administration of “weak” reinforcers in the rat Journal of Pharmacological and Toxicological Methods. 68: e8. DOI: 10.1016/J.Vascn.2013.01.037 |
0.263 |
|
| 2008 |
Staveley SM, O'Connor E, Parker D, Broad A, Mead A. Validation of rat behavioural models for the assessment of cannabinoid abuse potential Journal of Pharmacological and Toxicological Methods. 58: 167-167. DOI: 10.1016/J.Vascn.2008.05.087 |
0.259 |
|
| 2014 |
Ewart L, Aylott M, Deurinck M, Engwall M, Gallacher DJ, Geys H, Jarvis P, Ju H, Leishman D, Leong L, McMahon N, Mead A, Milliken P, Suter W, Teisman A, et al. The concordance between nonclinical and phase I clinical cardiovascular assessment from a cross-company data sharing initiative. Toxicological Sciences : An Official Journal of the Society of Toxicology. 142: 427-35. PMID 25246669 DOI: 10.1093/Toxsci/Kfu198 |
0.253 |
|
| 2013 |
Hsu C, Newman R, Shires S, Tse K, Warr A, Mead A, Waldron G. Use of the beam walking and drug discrimination models for determining intrinsic efficacy and selectivity of subtype selective GABA-A ligands in rodents Journal of Pharmacological and Toxicological Methods. 68: e8. DOI: 10.1016/J.Vascn.2013.01.038 |
0.25 |
|
| 2016 |
Mead AN, Amouzadeh HR, Chapman K, Ewart L, Giarola A, Jackson SJ, Jarvis P, Jordaan P, Redfern W, Traebert M, Valentin JP, Vargas HM. The predictive value of the rodent neurofunctional assessment for commonly reported adverse events in Phase I clinical trials. Regulatory Toxicology and Pharmacology : Rtp. PMID 27155597 DOI: 10.1016/J.Yrtph.2016.05.002 |
0.234 |
|
| 2010 |
Coles DI, Broad A, Mead A. Characterisation of pentobarbital physical dependence and withdrawal in rats Journal of Pharmacological and Toxicological Methods. 62: e9. DOI: 10.1016/J.Vascn.2010.11.029 |
0.229 |
|
| 2013 |
Ewart L, Amouzadeh H, Aylott M, Chapman K, Jordaan P, Leishman D, Locher K, Mead A, Murphy D, Scathcard J, Valentin J. Analysis of concordance of nonclinical rodent respiratory function measurements to phase i trial outcome using the animal model framework Journal of Pharmacological and Toxicological Methods. 68: e42-e43. DOI: 10.1016/J.Vascn.2013.01.154 |
0.204 |
|
| 2011 |
Newman RJ, Chime S, Waldron G, Mead A. Evaluation of contextual renewal as a nonclinical model for cognitive deficits Journal of Pharmacological and Toxicological Methods. 64: e24-e25. DOI: 10.1016/J.Vascn.2011.03.088 |
0.196 |
|
| 2015 |
Horton DB, Dunn-Sims E, Wager TT, Chang C, Doran A, Rosado A, Mead AN. Casein kinase-1 inhibitors as a novel treatment for substance use disorders Drug and Alcohol Dependence. 156: e98. DOI: 10.1016/J.Drugalcdep.2015.07.1184 |
0.196 |
|
| 2011 |
Tyszkiewicz CM, Cannon KE, Mead A. Short-term social isolation: A possible rodent model for a depressive-like state? Journal of Pharmacological and Toxicological Methods. 64: e21. DOI: 10.1016/J.Vascn.2011.03.077 |
0.188 |
|
| 2008 |
Bilsland JG, Wheeldon A, Mead A, Znamenskiy P, Almond S, Waters KA, Thakur M, Beaumont V, Bonnert TP, Heavens R, Whiting P, McAllister G, Munoz-Sanjuan I. Behavioral and neurochemical alterations in mice deficient in anaplastic lymphoma kinase suggest therapeutic potential for psychiatric indications. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 685-700. PMID 17487225 DOI: 10.1038/Sj.Npp.1301446 |
0.161 |
|
| 2017 |
Komen J, Gustafsson F, Basak J, Leonard E, Harding J, Mead A, Anderton M. Development of rat pancreatic acinar cell model for the assessment of drug induced injury caused by MCL1 inhibition Toxicology Letters. 280: S264-S265. DOI: 10.1016/J.TOXLET.2017.07.937 |
0.109 |
|
| 2023 |
Poulter S, Austin N, Armstrong R, Barnes M, Bucknell SJ, Higueruelo A, Banerjee J, Mead A, Mould R, MacSweeney C, O'Brien MA, Stott LA, Watson SP. The Identification of GPR52 Agonist HTL0041178, a Potential Therapy for Schizophrenia and Related Psychiatric Disorders. Acs Medicinal Chemistry Letters. 14: 499-505. PMID 37077397 DOI: 10.1021/acsmedchemlett.3c00052 |
0.072 |
|
| 2016 |
Kozyak BW, Mead A, Song Y, Morales L, Kornegay J, Stedman HH. 383. Clinico-Pathological Correlation in the Earliest Stages of Muscular Dystrophy Suggests Sensitive Physiological Parameters as Novel Primary Endpoints for Systemic Gene Therapy Molecular Therapy. 24: S153. DOI: 10.1016/S1525-0016(16)33192-6 |
0.033 |
|
| 2016 |
Mead A, Malik A, Krishnankutty R, Stedman HH. 389. Muscular Dystrophy Genes and the Early Metazoan Transition from Dynein- to Myosin-Powered Locomotion Molecular Therapy. 24: S154. DOI: 10.1016/S1525-0016(16)33198-7 |
0.011 |
|
| 2016 |
Song Y, Mead A, Petrov M, Ingraham P, Morales L, Rosenblum S, Kornegay J, Stedman HH. 388. Hypersensitivity of MYH16 Fibers (M Fibers) to Myodegeneration in Canine Muscular Dystrophy Molecular Therapy. 24: S154. DOI: 10.1016/S1525-0016(16)33197-5 |
0.01 |
|
| 1991 |
Mead A. Memories Draw Generations Back to Lynch Appalachian Heritage. 19: 20-22. DOI: 10.1353/APH.1991.0052 |
0.01 |
|
| Hide low-probability matches. |